A Feasibility Study for Cryopreserving Peripheral Blood Stem Cell Collects at High Cell Concentration

A Feasibility Study for Cryopreserving Peripheral Blood Stem Cell Collects at High Cell Concentration Jong Eun Park, Hae-Kyoung Choung, Hye-Kyung Park, Seung-Tae Lee, Seok-Jin Kim, Joon-Ho Jang, Ki-Hyun Kim, Won-Suk Kim, Chul-Won Chung, Eun-Suk Kang, Dae Won Kim Department of Laboratory Medicine and Genetics, Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

[1]  R. Bouabdallah,et al.  Automated washing of autologous hematopoietic stem cell grafts after thawing does not impair engraftment , 2014, Bone Marrow Transplantation.

[2]  S. Heimfeld,et al.  Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion , 2014, Bone Marrow Transplantation.

[3]  M. Głowala‐Kosińska,et al.  Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells , 2013, Vox sanguinis.

[4]  K. Chan,et al.  High white blood cell concentration in the peripheral blood stem cell product can induce seizures during infusion of autologous peripheral blood stem cells. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  C Tarella,et al.  Proposed definition of ‘poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo , 2011, Bone Marrow Transplantation.

[6]  J. Kastrup,et al.  Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide , 2012, Cell and Tissue Banking.

[7]  Jihun Hamm,et al.  Cryopreservation of Collected Peripheral Blood Hematopoietic Stem Cell Product with 5% DMSO by Adding Nontoxic Natural Cryoprotectants , 2011 .

[8]  J. Mandumpal,et al.  A molecular mechanism of solvent cryoprotection in aqueous DMSO solutions. , 2011, Physical chemistry chemical physics : PCCP.

[9]  J. Huh,et al.  Assessment of Cell Viability in Umbilical Cord Blood before Cryopreservation , 2010 .

[10]  B. Labar,et al.  Toxicity related to autologous peripheral blood haematopoietic progenitor cell infusion is associated with number of granulocytes in graft, gender and diagnosis of multiple myeloma , 2008, Vox sanguinis.

[11]  M. Cairo,et al.  Determining post‐thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity , 2008, Vox sanguinis.

[12]  Ø. Bruserud,et al.  Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation , 2008, Transfusion.

[13]  Mark Ende,et al.  Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.

[14]  C. Azqueta,et al.  Cryopreservation of hematopoietic progenitor cells from apheresis at high cell concentrations does not impair the hematopoietic recovery after transplantation , 2005, Transfusion.

[15]  M. Kneba,et al.  Establishment and optimization of a flow cytometric method for evaluation of viability of CD34+ cells after cryopreservation and comparison with trypan blue exclusion staining , 2005, Transfusion.

[16]  M. Skinner,et al.  Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis , 2005, Bone Marrow Transplantation.

[17]  D. Kadidlo,et al.  Patient care during infusion of hematopoietic progenitor cells , 2004, Transfusion.

[18]  Carlota Saldanha,et al.  Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. , 2003, Biochemical pharmacology.

[19]  G. Martinelli,et al.  Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases , 1999, Bone Marrow Transplantation.

[20]  S. Heimfeld,et al.  Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components. , 1999, Cytotherapy.

[21]  J. Gorlin.  Stem cell cryopreservation. , 1996, The Journal of infusional chemotherapy.

[22]  T. Gooley,et al.  Effect of Cell Concentration on Bone Marrow and Peripheral Blood Stem Cell Cryopreservation , 1994 .

[23]  T. Gooley,et al.  Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. , 1994, Blood.

[24]  S. Rowley,et al.  Hematopoietic stem cell cryopreservation: a review of current techniques. , 1992, Journal of hematotherapy.